Cancer Research UK National Biomarker Centre

Cancer Research UK National Biomarker Centre is a leading translational research center dedicated to advancing cancer detection and treatment. Core funded by Cancer Research UK, the center focuses on the discovery, development, validation, and qualification of biomarkers in clinical studies and trials. These biomarkers aim to detect cancer earlier and predict and monitor therapy responses, ultimately supporting optimized treatment for patients.

With advanced research programs that are agnostic to cancer type, Cancer Research UK National Biomarker Centre develops biomarkers in tissue and less invasive clinical samples such as blood (liquid biopsy). The center employs sophisticated bioinformatic and artificial intelligence solutions for multi-modal laboratory and clinical biomarker data analysis and interpretation. Preclinical programs are focused on the development of pharmacodynamic biomarkers and the evaluation of the efficacy of novel therapeutics in patient-derived models.

As a crucial bridge between discovery science and clinical research, Cancer Research UK National Biomarker Centre fosters collaborations across Manchester, nationally, and internationally. Cancer Research UK National Biomarker Centre is committed to making significant strides in cancer research and patient care. We invite the manager of Cancer Research UK National Biomarker Centre to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and impact in the research community.